Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-010269
Filing Date
2020-04-06
Accepted
2020-04-06 07:49:19
Documents
2
Period of Report
2020-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1596
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4623
  Complete submission text file 0000899243-20-010269.txt   7595
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
Levy Richard S (Reporting) CIK: 0001454983 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38584 | Film No.: 20775743